Most Recent
Heinz drops appeal in sugary kids snacks case
Appeals 2018-10-24 12:35 pm By Cat Fredenburgh

H.J. Heinz Company has dropped its appeal of a ruling that it marketed its sugary snacks to kids as healthy, after the ACCC won a fraction of the $10 million fine it sought for the consumer law violations.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Slater and Gordon wins $12.7M in fees in Provident class action
Class Actions 2018-10-23 6:36 pm By Miklos Bolza

The NSW Supreme Court has approved a $44.25 million settlement of two class actions against the trustees of failed debenture issuer Provident Capital, including $12.8 million in legal fees for Slater and Gordon and $4.3 million for funder Litman Holdings.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Hastie liquidators pick two test cases over unpaid bills, but stay bid coming
Construction 2018-10-23 12:24 pm By Christine Caulfield

Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bannister Law off Ford class action in wake of funder feud
Class Actions 2018-10-22 3:49 pm By Cat Fredenburgh

Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that’s backing the case.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Apotex settles patent suit over generic Lexapro
Intellectual Property 2018-10-19 8:22 pm By Christine Caulfield

Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AFT Pharma’s Maxigesic ads misleading, judge rules
Competition & Consumer Protection 2018-10-18 11:22 pm By Christine Caulfield

AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Wyeth resolves Commonwealth’s claims over generic Effexor delay
Intellectual Property 2018-10-18 10:40 pm By Christine Caulfield

The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Goodyear hits the brakes on trade mark appeal against Dunlop
Intellectual Property 2018-10-11 4:44 pm By Cat Fredenburgh

US tyre company Goodyear has dropped its challenge to a mixed trade mark ruling in its long-running dispute with UK-based rival Dunlop over coveted trade marks for ‘Dunlop’ and ‘Flying D’.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fortescue unit can eyeball Squire Patton Boggs emails in power contract dispute
Energy & Natural Resources 2018-10-03 3:51 pm By Miklos Bolza

A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs  and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘I just don’t get it’: judge questions Sandoz cross claim in Lexapro patent case
Intellectual Property 2018-10-02 9:25 pm By Miklos Bolza

A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?